A Study of Pertuzumab in Participants With Metastatic Breast Cancer
Clinical trial NCT02491892 · COMPLETED
Trial details
- NCT number
- NCT02491892
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2005-04-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.